Metabolic & Kidney Kidney Damage · Diabetic Nephropathy

💧 UACR — Urine Albumin:Creatinine Ratio

The most sensitive early warning sign of kidney damage — before eGFR declines

Albumin doesn't normally appear in urine. When the kidney's filtration barrier is damaged by diabetes, hypertension, or autoimmune disease, albumin leaks through — detectable years before creatinine rises or eGFR falls. UACR detects this damage early.

Type Ratio measurement — urine albumin (mg/L) ÷ urine creatinine (g/L or mmol/L)

Produced by Albumin leaks from glomerular filtration barrier when damaged; creatinine in urine used to correct for urine concentration

Half-life N/A — ratio from spot urine specimen (preferably first morning void)

Units mg/g (mg albumin per gram creatinine) or mg/mmol

Clinical Overview

Under normal conditions, the glomerular filtration barrier (podocytes, basement membrane, endothelial fenestrations) prevents albumin from entering the primary filtrate. Even the small amount that crosses is completely reabsorbed in the proximal tubule. When the barrier is damaged, albumin leaks into urine in amounts detectable years before creatinine-based eGFR decline — making UACR the earliest laboratory indicator of diabetic nephropathy and hypertensive kidney damage.

Normal range < 30 mg/g: Normal (A1) · 30–300 mg/g: Moderately increased (A2) — "microalbuminuria" · > 300 mg/g: Severely increased (A3) — "macroalbuminuria"

Reference Ranges

How clinicians interpret UACR (Urine Albumin:Creatinine Ratio) results — from optimal to concerning.

< 30 mg/g mg/g (mg albumin per gram creatinine) or mg/mmol

Normal. No significant glomerular barrier damage detected.

30–300 mg/g mg/g (mg albumin per gram creatinine) or mg/mmol

Moderately increased (A2). Early diabetic/hypertensive nephropathy. Intensify BP and glucose control. Confirm on 2 of 3 samples.

> 300 mg/g mg/g (mg albumin per gram creatinine) or mg/mmol

Severely increased (A3) — macroalbuminuria. Advanced nephropathy. Nephrology referral and maximum RAAS blockade.

> 2,200 mg/g mg/g (mg albumin per gram creatinine) or mg/mmol

Nephrotic-range proteinuria. Glomerulonephritis, nephrotic syndrome. Urgent nephrology and renal biopsy consideration.

⚠ Reference ranges vary by laboratory and assay. Always interpret your result in context of your laboratory's own reference intervals and your clinical presentation.

What raises UACR (Urine Albumin:Creatinine Ratio)

🩸

Diabetes mellitus

Hyperglycaemia causes podocyte injury, basement membrane thickening, and mesangial expansion — progressive UACR rise is the hallmark of diabetic nephropathy.

💓

Hypertension

Elevated intraglomerular pressure damages the filtration barrier — UACR is the earliest renal damage marker in hypertension.

🏃

Strenuous exercise (transient)

Exercise-induced glomerular pressure rise transiently elevates UACR — always test from first morning void on a rest day.

🦠

Urinary tract infection

UTI causes false-positive UACR — always confirm elevated UACR on a second sample after excluding infection.

🧬

Lupus nephritis

Immune complex deposition in glomeruli — rapid UACR rise with active lupus nephritis requires urgent immunosuppression.

🤰

Pre-eclampsia

UACR > 30 mg/g (or 300 mg/24h) in pregnancy is a diagnostic criterion for pre-eclampsia.

What lowers UACR (Urine Albumin:Creatinine Ratio)

💊

ACE inhibitors / ARBs

RAAS blockade reduces intraglomerular pressure and has direct anti-proteinuric effects. Most effective pharmacological intervention.

💉

SGLT2 inhibitors

Reduce UACR by 30–40% in diabetic nephropathy — via haemodynamic (afferent arteriole constriction) and tubuloglomerular mechanisms.

💓

Blood pressure control

Target BP < 130/80 mmHg in CKD with proteinuria significantly slows UACR rise and GFR decline.

🩸

HbA1c optimisation

In diabetic nephropathy, improving HbA1c from 9% to 7% reduces new microalbuminuria risk by ~30%.

🔬

Finerenone (nonsteroidal MRA)

Novel mineralocorticoid receptor antagonist — reduces UACR and CKD progression in T2DM independently of BP effect.

Conditions this biomarker signals

When UACR (Urine Albumin:Creatinine Ratio) is outside normal range, these are the most clinically significant possibilities.

↑ Diabetic nephropathy Monitor

UACR ≥ 30 mg/g is the earliest objective marker of diabetic kidney damage — years before eGFR falls. Annual screening in all diabetics.

↑ Hypertensive kidney disease Monitor

UACR ≥ 30 mg/g in hypertension = target organ damage — intensify BP control, initiate ACEi/ARB.

↑ Pre-eclampsia Urgent review

UACR ≥ 30 mg/g in pregnancy ≥ 20 weeks with hypertension = pre-eclampsia. Admission and delivery planning.

↑ Lupus nephritis Urgent review

Rapid UACR rise in SLE = possible lupus nephritis — urgent renal biopsy and immunosuppression assessment.

Which tests measure this biomarker

UACR (Urine Albumin:Creatinine Ratio) may be included in or ordered alongside these panels.

Spot UACR — first morning void preferred

Confirm elevated result on 2 of 3 samples 1–4 weeks apart (excluding UTI, exercise, menstruation). Avoids transient causes.

24-hour urine albumin (less convenient)

Gold standard measurement — UACR is validated as equivalent and preferred for routine screening.

How the glomerular filtration barrier keeps albumin out of urine

The glomerular filtration barrier has three layers working in concert: the endothelial fenestrations (size barrier), the glomerular basement membrane (charge and size barrier), and podocyte foot processes (slit diaphragm — final charge barrier). Albumin (67 kDa, negatively charged) is normally excluded by the negative charge of the basement membrane and the narrow slit pores of the podocyte diaphragm. When diabetes or hypertension damages podocytes, the slit diaphragm proteins (nephrin, podocin) are downregulated — albumin leaks through. Even nanomolar quantities are detectable in urine years before structural GFR decline — this is why UACR rises before eGFR falls.

A1→A2→A3

CKD staging uses both eGFR (G1–G5) and UACR (A1–A3)

KDIGO 2012 introduced the combined GFR-albuminuria staging system for CKD — recognising that UACR independently predicts CKD progression risk even at normal eGFR. A patient with eGFR 65 (G2) and UACR 200 (A2) has significantly higher risk than eGFR 65 + UACR 15 (A1) — the full 3×3 grid determines prognosis and management intensity.

CREDENCE

SGLT2 inhibitors transform diabetic nephropathy outcomes

The CREDENCE trial (canagliflozin, T2DM + CKD) showed 34% reduction in primary renal composite endpoint. Importantly, UACR reduction was the earliest measurable pharmacodynamic effect — preceding eGFR stabilisation. SGLT2 inhibitors are now first-line for CKD with proteinuria in T2DM across major guidelines.

Pre-E

UACR > 30 mg/g in pregnancy can signal pre-eclampsia

Pre-eclampsia affects 2–8% of pregnancies. UACR ≥ 30 mg/g combined with blood pressure ≥ 140/90 mmHg after 20 weeks of gestation meets diagnostic criteria. UACR provides rapid, quantitative proteinuria assessment without requiring 24-hour urine collection — a significant logistical advantage in obstetric settings.

Clinical use — when and why this is ordered

How clinicians use UACR (Urine Albumin:Creatinine Ratio) in practice — the real-world scenarios where it changes decisions.

🩺

Annual diabetes CKD screening

UACR + eGFR annually in all type 2 diabetics; type 1 from 5 years post-diagnosis. First-morning void avoids exercise and diurnal variation.

💓

Hypertensive nephropathy monitoring

UACR at diagnosis of hypertension and annually in uncontrolled hypertension — tracks target organ damage and guides ACEi/ARB initiation.

💊

SGLT2 inhibitor selection in CKD

UACR ≥ 200 mg/g in T2DM + CKD = highest benefit from SGLT2 inhibitors for renoprotection based on CREDENCE/DAPA-CKD trial data.

🧬

Lupus nephritis monitoring

Serial UACR tracks response to immunosuppression in lupus nephritis — rising UACR during apparent remission indicates ongoing subclinical activity.